Success Stories: NIW Approval Received for a Bioinformatics Analyst/Programmer III in the Field of Computational Biology Hailing from India with our Assiduous Efforts

 

Client’s Testimonial:

“Thanks for all the help.”


On September 21st, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Bioinformatics Analyst/Programmer III in the field of Computational Biology (Approval Notice).


General Field: Computational Biology

Position at the Time of Case Filing: Bioinformatics Analyst/Programmer III

Country of Origin: India

State of Residence at the Time of Filing: Ohio

Approval Notice Date: September 21st, 2021

Processing Time: 13 months, 10 days


Case Summary:

To obtain various kinds of immigration and non-immigrant visas for entry and stay in the United States of America, North America Immigration Law Group is poised at the center of the legal path one needs to take. Our job is to make sure that every client reaching out to us for help in the process, gets the best legal aid possible.

  • And this is precisely what has made it possible for us to win over 25,000 cases to date.
So, when a bioinformatics analyst/programmer III in the field of computational biology came to us asking for help with his (National Interest Waiver) petition, we made sure that his case was prepared to achieve success.

To make a victorious case on his behalf, our team came together to do a complete background check before building his petition packet.

  • In this packet was included data from his publication and citations records plus testimonials of 4 experts in the field of which one was known to the client personally and the rest knew him through his excellent work in the field.
As an expert in his field of computational biology, we found that his proposed endeavor is to develop computational biology algorithms to determine ideal biomarkers and therapeutic targets for cancer treatment.
  • Specifically, he will develop, refine, and apply computational biology algorithms and use Artificial Intelligence-based approaches to analyze and interpret cancer molecular and imaging data and to identify biomarkers and therapeutic targets for various types of cancers to improve precision medicine strategies in cancer patients.
Furthermore, the value of his work became even more important when he received letters of support stating the value of his work to his peers and the country. A few excerpts out of the four are mentioned below:

“...However, [client’s] research, focused as it is on applying computational methods and artificial intelligence to decode complex biological mechanisms, is dedicated to lowering the cost and complexity of cancer research, better leveraging massive datasets to help develop effective cancer therapies, and studies. In this way, [client] has established himself as a major asset to the mission of fighting cancer in the United States.”

“...[Client] has marshaled his skills in bioinformatics and computational biology to approach the study of cancer from an innovative angle, using big data and artificial intelligence algorithms to decode biologic mechanisms and inform the design of biomarkers and therapeutic strategies for this deadly disease. Considering this information, it is abundantly clear that [client] [is] a major asset to American public health.”

In addition to the above-mentioned details, our client’s research work culminated in:

  • 13 peer-reviewed journal articles, 1 book chapter, and 1 patent application
  • Publications have been cited a total of 147 times according to Google Scholar
Also, his research was highlighted in an article on ScienceDaily, a website that publishes breaking science news and articles on a variety of topics:
  • The article discussed his work on the ability of “smart” diagnostic-imaging machines to identify cancers and determine how patients respond to chemotherapy.
Thus, our client’s education and training, his documented record of scholarly publication, the recognized influence of his research in the field, and his clear future research plans demonstrate that he is well-positioned to advance research in his field of expertise.

We are very proud of having had the opportunity to be a part of his NIW approval journey. We wish him the very best in all his future endeavors.